Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paolo G. Gobbi
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study
Haematologica
Hematology
Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Long-Term Quality of Life in Patients With Advanced Hodgkin Lymphoma: A Systematic Review
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Long-Term Results and Competing Risk Analysis of the H89 Trial in Patients With Advanced-Stage Hodgkin Lymphoma: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1-3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma
Journal of Tumour Research & Reports
